|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Pulmonary and Critical Care Unit, Department of Medicine (Dr. Thompson), Department of Biostatistics (Mr. Hayden), Massachusetts General Hospital and Harvard Medical School, Boston, MA; Division of Pulmonary and Critical Care Medicine, Department of Medicine, the Department of Anesthesia, and the Cardiovascular Research Institute (Dr. Matthay), University of California, San Francisco, San Francisco, CA; Division of Pulmonary and Critical Care Medicine (Dr. Brower), Johns Hopkins University, Baltimore, MD; and Pulmonary and Critical Care Unit (Dr. Parsons), Fletcher Allen Health Care, Burlington, VT.
Correspondence to: B. Taylor Thompson, MD, Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114; e-mail: tthompson1{at}partners.org
| Abstract |
|---|
|
|
|---|
300) and compare ventilator
settings in patients with ARDS
(PaO2/FIO2
200) to
settings in patients with milder oxygenation impairment
(PaO2/FIO2 of 201 to
300). Design: Retrospective analysis of baseline data from prospective randomized trials conducted by the National Institutes of Health ARDS Network between 1996 and 1999.
Setting: Ten clinical centers comprising 24 hospitals and 74 medical and surgical ICUs of the ARDS Network.
Measurements and
results: The most common mode of mechanical ventilation in both
groups was volume-assist control (56%). Synchronized intermittent
mandatory ventilation (SIMV) or SIMV with pressure support was used
more often in patients with
PaO2/FIO2 of 201 to 300
than in patients with ARDS. The use of pressure-control ventilation was
uncommon (10% overall), as was the use of permissive hypercapnia (6%
of patients with ARDS and 3% of patients with
PaO2/FIO2 of 201 to
300). The mean ± SD tidal volume was 10.3 ± 2 mL/kg of predicted
body weight or 8.6 ± 2 mL/kg of measured weight for patients with
ARDS, and was not significantly different for patients with
PaO2/FIO2 of 201 to
300. Plateau pressures (Pplats) were lower in the
PaO2/FIO2 of 201 to 300
group (27 ± 7 vs 31 ± 8 for the ARDS group; p = 0.0003) and
were > 35 cm H2O in 26% of patients. Seventy-eight
percent of patients with ARDS received
10 cm H2O of
positive end-expiratory pressure.
Conclusions: Physicians in ARDS Network centers caring for patients early in the course of ALI/ARDS used volume-targeted ventilation and selected tidal volumes that resulted in Pplats generally < 35 cm H2O. The average tidal volume was similar for patients with ARDS vs those with milder oxygenation deficits.
Key Words: acute lung injury ARDS mechanical ventilation
| Introduction |
|---|
|
|
|---|
The purpose of this study is to examine recent ventilator practices of clinicians caring for patients with ALI and ARDS. We reviewed ventilator settings of ALI/ARDS patients before enrollment in clinical trials conducted by the National Institutes of Health, National Heart, Lung, and Blood Institute ARDS Network.
| Materials and Methods |
|---|
|
|
|---|
Patients were eligible if they required mechanical ventilation for the
acute onset of PaO2/fraction of
inspired oxygen (FIO2)
300
(altitude adjustment in Denver and Salt Lake City), bilateral pulmonary
infiltrates consistent with pulmonary edema, and no clinical evidence
of left atrial hypertension. If measured, the pulmonary capillary wedge
pressure was required to be
18 mm Hg.
Exclusion criteria included > 36 h elapsed since the above-mentioned inclusion criteria were met, age < 18 years, participation in other ALI/ARDS trials within 30 days, pregnancy, increased intracranial pressure, neuromuscular disease that could impair spontaneous breathing, sickle-cell disease, severe chronic respiratory disease, massive obesity, > 30% body surface area burns, comorbid conditions with estimated 6-month mortality > 50%, bone marrow or lung transplant, chronic liver disease (Child-Pugh class C), or attending physician refusal or unwillingness to commit full life support. Values closest to the time of initial protocol-specified ventilator change were chosen. Tidal volume was corrected for volume lost from gas compression and ventilator tubing compliance and expressed per kilogram of PBW as previously described.4
Mean values ( ± SD) for patients with ARDS vs patients with
PaO2/FIO2
of 201 to 300 were compared with Students t test for
continuous variables and a
2 test for
dichotomous variables. Linear and logistic regression were used to test
the association of selected variables and covariates. Two-sided p
values of < 0.05 were accepted as indicating statistical
significance. All analyses were conducted with SAS version 6.12 (SAS
Institute; Cary, NC).
| Results |
|---|
|
|
|---|
Data on baseline ventilator settings (used in the 4-h interval prior to
the initial protocol-specified ventilator changes) and arterial blood
gas values indicating a
PaO2/FIO2
300 were available in 814 of the 902 patients and comprise the
basis of this report (88 patients excluded). Modes of ventilation at
baseline for patients with ALI, those with ARDS
(PaO2/FIO2
200), and those at the milder end of the ALI spectrum
(PaO2/FIO2
of 201 to 300) are shown in Table 1
. The most common mode of mechanical ventilation used in all groups was
volume-assist control (56%). Synchronized intermittent mandatory
ventilation (SIMV) or SIMV plus pressure support was used more often in
patients with
PaO2/FIO2
of 201 to 300 than in patients with
PaO2/FIO2
200. The use of the pressure-control mode was uncommon (10%
overall) and almost entirely confined to patients with ARDS (77 of 84
patients). The proportion of patients receiving volume-assist control
was similar (61%) for those excluded from the study.
|
200.
|
Table 3 shows ventilator settings, airway pressures, and arterial blood gas values for patients whose baseline ventilator mode was pressure targeted rather than volume targeted. Pressure-targeted ventilation was defined as pressure control or pressure support as the sole mode of mechanical ventilation. There were no significant differences in the levels of pressure control, pressure support, or total respiratory rate between patients with ARDS vs those with PaO2/FIO2 of 201 to 300. Patients with PaO2/FIO2 of 201 to 300 received lower levels of PEEP. Only 10 patients received pressure-controlled inverse-ratio ventilation (PCIRV).
|
50 mm Hg, occurred in
6% of patients with ARDS and 3% of patents with
PaO2/FIO2
of 201 to 300.
The levels of PEEP used for the entire ALI cohort ranged from 2 to 28
cm H2O, and 16 patients (14 patients with ARDS)
were treated with zero end-expiratory pressure. Seventy-eight percent
of patients with ARDS received
10 cm H2O, and
97% received
15 cm H2O PEEP. For patients
with
PaO2/FIO2
of 201 to 300, 88% received
10 cm H2O and
98% received
15 cm H2O PEEP. Figure 1 shows the mean PEEP levels used over a range of
FIO2 values from 0.3 to 1.0 for all
patients. Higher levels of PEEP correlated with higher inspired oxygen
levels (p < 0.0001).
|
| Discussion |
|---|
|
|
|---|
These findings are consistent with a survey3 of critical-care practitioners preferences obtained in late 1992 and published in 1996. The most favored modes of mechanical ventilation for patients with ARDS were volume-assist control (approximately 65%) and intermittent mandatory ventilation (approximately 20%). In the ARDS network studies, baseline tidal volumes in patients with volume-targeted ventilation were 10.3 ± 2 mL/kg PBW, or approximately 9 mL/kg of measured weight, which was within the range of tidal volumes most commonly preferred by survey respondents.3
The mean Pplat of 31 ± 8 cm H2O in patients with ARDS in this study was consistent with the consensus conference recommendations1 to limit end-inspiratory pressure to < 35 cm H2O. However, in 28% of patients receiving volume-targeted ventilation, Pplat exceeded this limit prior to enrollment in the ARDS Network trials.
Baseline tidal volumes used before enrollment in the ARDS Network trials are compared to tidal volumes used by clinicians and investigators in several studies conducted from 1989 to 1999 (Table 4 ). In the multicenter, international trial of aerosolized surfactant in ARDS (A. Anzueto, MD; personal communication; March 2000),9 the mean tidal volume on the day of study enrollment was 11.4 mL/kg of measured body weight, which is equivalent to approximately 13.7 mL/kg PBW. In the seven-center trial of ibuprofen in sepsis (G. Bernard, MD; personal communication; March 2000),10 the mean tidal volume among intubated patients with ALI on the day of enrollment was 10.3 mL/kg of measured body weight, equivalent to approximately 12.4 mL/kg PBW. These tidal volumes were prescribed by clinicians working in ICUs that were not participating in trials of pressure-limited and volume-limited mechanical ventilation strategies. Hence, these tidal volumes likely represent the standard practice for initial ventilator management of patients with ALI/ARDS during the time these studies were conducted (from 1989 to 1995).
|
The tidal volumes used by investigators in the traditional arm of the ARDS Network study, the control group of the pressure-limited and volume-limited study by Stewart et al,5 and in the "conventional" arm used by Brochard et al6 were, on average, intermediate between the tidal volumes selected by clinicians caring for patients earlier vs later in the 1990s (Table 4) .4 11 Thus, investigators designing trials of lower tidal volume ventilation in the mid-1990s appear to have selected "control" tidal volumes representative of an evolving practice toward the use of lower tidal volumes during this decade.
While there may have been a modest reduction of tidal volumes over the past decade, it is important to note that the tidal volume used in the ARDS Network ventilation management strategy that was ultimately found to be associated with improved outcome is substantially smaller yet. That strategy targeted a tidal volume of 6 mL/kg PBW (approximately 5 mL/kg of measured weight) that was further reduced, if needed, to a minimum of 4 mL/kg PBW to maintain a Pplat < 30 cm H2O.4 Additional studies will be needed to see if the results of the ARDS Network trial will accelerate the use of these much lower tidal volumes for the management of patients with ALI/ARDS.
In 1994, an American-European Consensus Conference on ALI and ARDS
recommended a definition for ARDS that incorporated a
PaO2/FIO2
threshold
200. The recommended definition of ALI was the same as
for ARDS, except for a
PaO2/FIO2
threshold
300.2
ALI thus refers to all patients with a
PaO2
300, including the subset
with ARDS. Studies12
13
have suggested that the
clinical characteristics, risk factors for lung injury, and outcomes
are similar for patients with ALI vs the subset of patients with ARDS.
We anticipated that ventilator support would differ in patients across the spectrum of ALI, with low tidal volume ventilation or pressure-targeted ventilation used more commonly in patients with more severe oxygenation deficits. There were modest differences in modes of ventilation used for patients with ARDS vs those with PaO2/FIO2 of 201 to 300, with slightly more use of SIMV and less use of pressure control for the PaO2/FIO2 of 201 to 300 group. However, volume-targeted ventilation was used in a large majority of both the ARDS and PaO2/FIO2 of 201 to 300 groups, and pressure-control ventilation, especially PCIRV, was infrequently used.
Optimal use of PEEP and supplemental oxygen is also
controversial.14
Most intensivists adjust PEEP and
FIO2 to achieve an arterial
oxygenation goal. In this study, physicians used, on average, 8.8-cm
H2O PEEP and an
FIO2 of 0.67 early in the course of
patients with ARDS to achieve an average
PaO2 of 78 mm Hg. Two
studies8
15
of lung-protective ventilatory strategies
incorporating higher PEEP levels (set on the basis of pressure-volume
curves) have demonstrated reduced mortality or diminished lung and
systemic cytokine release. The mean levels of PEEP on the first day of
these two trials were 16.3 ± 0.7 cm H2O and
14.7 ± 2.7 cm H2O in the lung-protective
groups. PEEP levels in the control groups were set to meet oxygenation
goals and were 6 to 7 cm H2O. The levels of PEEP
reported in the present study are similar to those in these control
groups, and only 3% of patients with ARDS received
15 cm
H2O of PEEP. These findings suggest that a
traditional approach was used to set PEEP in the patients described
herein.
There are some limitations to this study. First, the ventilator approaches reported in Tables 1 2 3 represent ventilator settings clinicians prescribed only during the first 36 h after onset of ALI or ARDS. We do not know if these approaches would have been maintained in the subsequent clinical courses. It is possible that tidal volumes would have been reduced or PEEP levels increased in some patients to limit inspiratory airway pressures or FIO2, respectively. Second, it is possible that the ventilator approaches used in the initial phase of ALI were influenced by clinicians familiarity with the ongoing ARDS Network trials, which used volume-assist control mode in all patients before weaning.4 Moreover, clinicians may have prescribed lower tidal volumes before their patients enrollments because the ARDS Network trial increased their concerns for overdistention or stretch-induced lung injury. The reduction in tidal volumes following completion of the ventilator trial suggests that clinicians practicing in ARDS Network hospitals were aware of and probably influenced by the study. Third, we do not have clinician-prescribed ventilator settings for patients excluded from the ARDS Network trial. These patients represent 88% of all patients with ALI identified in the network ICUs.
In summary, physicians caring for patients early in the course of ALI in ARDS Network hospitals favored volume-targeted ventilation and selected tidal volumes that resulted in Pplats generally < 35 cm H2O, in accordance with consensus recommendations. SIMV with or without pressure support was used more often in the PaO2/FIO2 of 201 to 300 group vs the ARDS subset, while pressure control, especially PCIRV, was uncommonly used. The average tidal volume (8.6 mL/kg of measured weight or 10.3 mL/kg PBW) was similar across the spectrum of PaO2/FIO2, was similar to the tidal volumes reported in a recent international survey, but was lower than tidal volumes used earlier in the 1990s. It remains to be seen if the results of recent clinical trials will accelerate the apparent evolution of practice toward using lower tidal volume ventilation for the management of ALI.
| Footnotes |
|---|
Supported by contracts NO1-HR 4605464 from the National, Heart, Lung, and Blood Institute.
Received for publication January 22, 2001. Accepted for publication April 11, 2001.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. Kornecki, S. Tsuchida, H. K. Ondiveeran, D. Engelberts, H. Frndova, A. K. Tanswell, M. Post, C. McKerlie, J. Belik, A. Fox-Robichaud, et al. Lung Development and Susceptibility to Ventilator-induced Lung Injury Am. J. Respir. Crit. Care Med., April 1, 2005; 171(7): 743 - 752. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Mentzelopoulos, C. Roussos, and S. G. Zakynthinos Prone position reduces lung stress and strain in severe acute respiratory distress syndrome Eur. Respir. J., March 1, 2005; 25(3): 534 - 544. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. S. Hoo Off Label, On Target? Chest, October 1, 2004; 126(4): 1022 - 1025. [Full Text] [PDF] |
||||
![]() |
C. S. Parshuram and B. P. Kavanagh Positive Clinical Trials: Understand the Control Group before Implementing the Result Am. J. Respir. Crit. Care Med., August 1, 2004; 170(3): 223 - 226. [Full Text] [PDF] |
||||
![]() |
The National Heart, Lung, and Blood Institute ARDS Higher versus Lower Positive End-Expiratory Pressures in Patients with the Acute Respiratory Distress Syndrome N. Engl. J. Med., July 22, 2004; 351(4): 327 - 336. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Brower, G. Rubenfeld, and B. T. Thompson Meta-analysis of tidal volumes in ARDS Am. J. Respir. Crit. Care Med., July 15, 2003; 168(2): 255 - 256. [Full Text] [PDF] |
||||
![]() |
B. Priolet, D. Robert, R. G. Brower, M. A. Matthay, and G. R. Bernard Questions about ARDSNetwork trial of low tidal volume Am. J. Respir. Crit. Care Med., June 15, 2003; 167(12): 1717 - 1717. [Full Text] [PDF] |
||||
![]() |
J.-D. Ricard Are We Really Reducing Tidal Volume--And Should We? Am. J. Respir. Crit. Care Med., May 15, 2003; 167(10): 1297 - 1298. [Full Text] [PDF] |
||||
![]() |
C. R. Weinert, C. R. Gross, and W. A. Marinelli Impact of Randomized Trial Results on Acute Lung Injury Ventilator Therapy in Teaching Hospitals Am. J. Respir. Crit. Care Med., May 15, 2003; 167(10): 1304 - 1309. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Steinbrook How Best to Ventilate? Trial Design and Patient Safety in Studies of the Acute Respiratory Distress Syndrome N. Engl. J. Med., April 3, 2003; 348(14): 1393 - 1401. [Full Text] [PDF] |
||||
![]() |
P. Q. Eichacker, E. P. Gerstenberger, S. M. Banks, X. Cui, and C. Natanson Meta-Analysis of Acute Lung Injury and Acute Respiratory Distress Syndrome Trials Testing Low Tidal Volumes Am. J. Respir. Crit. Care Med., December 1, 2002; 166(11): 1510 - 1514. [Full Text] [PDF] |
||||
Read all eLetters
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |